Capital Impact Advisors, LLC Exelixis, Inc. Transaction History
Capital Impact Advisors, LLC
- $75.1 Million
- Q1 2024
A detailed history of Capital Impact Advisors, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Capital Impact Advisors, LLC holds 42,909 shares of EXEL stock, worth $948,288. This represents 1.35% of its overall portfolio holdings.
Number of Shares
42,909Holding current value
$948,288% of portfolio
1.35%Shares
11 transactions
Others Institutions Holding EXEL
# of Institutions
460Shares Held
246MCall Options Held
1.7MPut Options Held
1.02M-
Black Rock Inc. New York, NY34.9MShares$771 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.8MShares$681 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA26.7MShares$590 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.1MShares$334 Million0.56% of portfolio
-
State Street Corp Boston, MA13.1MShares$289 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $7.11B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...